Senior > Diabetes

Faricimab approval, home OCT mark major developments in retina

7 monthes ago   |   By Healio

WASHINGTON - Recent developments in the retina field include increasingly durable therapeutics for vascular disease, according to a speaker here.
“It's an exciting time in the world of retina,” Brian K. Do, MD, said at the American Society of Cataract and Refractive Surgery meeting.
Do discussed updates in the specialty, such as the approval of faricimab for neovascular age-related macular degeneration and diabetic macular edema. Because faricimab is a bispecific monoclonal antibody, it is able to inhibit both VEGF-A and Ang-2.
“Ang-2 is thought, when inhibited, to
Read more ...

 


Search by Tags

   Diabetes      Cataract  


Alzheimer's Network for Treatment and Diagnostics created to collect...

Alzheimer's Network for Treatment and Diagnostics created to collect real-world data

The Alzheimer's Association is among a group of professional societies and research institutions that have launched the Alzheimer's Network for Treatment and Diagnostics to... Read more ...

Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?

Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?

SAN DIEGO - Whether it's due to the side effects of local and systemic therapies, or the diagnosis itself, men with prostate cancer are at increased risk of mental distress and... Read more ...

Bromocriptine appears to drop BP, improve arterial stiffness in teens with...

Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes

Bromocriptine, a drug previously used to treat adults with type 2 diabetes and Parkinson's disease, improved BP and central and peripheral aortic stiffness over 4 weeks in... Read more ...